A Medical Device Daily

Life Science Intelligence (LSI; Huntington Beach, California) reported that another new group of 22 mostly private med-tech companies have recently been added to the Emerging Medical Technologies (EMT) Database.

According to LSI, the latest round of companies is collectively seeking $156 million ($1 million seed, $25 million Series B, $39.5 million Series C, $25 million series E, $20.5 million Series F, and $44.75 million undisclosed). Many of the companies are also actively pursuing strategic partnerships and licensing deals with larger companies, LSI noted.

LSI's EMT Database provides medical technology executives and venture capitalists with a searchable online resource allowing them to discover, partner, and capitalize on opportunities in emerging med-tech start-up companies. Most of the companies in the database include executive summaries and presentations.

Start-ups in the EMT Database represent many market segments, including aesthetics, biomaterials, biotechnology, cardiovascular, cell therapy, dental, dermatology, diagnostics, drug delivery, endocrine, gastroenterology, gynecology, imaging, men's health, neurology, oncology, ophthalmology, orthopedics, pain management, patient monitoring, respiratory, spine, surgery, urology, vascular, women's health, and wound management.

LSI delivers market data and information to medical technology executives, entrepreneurs, and investors. LSI produces the EMT Database, med-tech market reports, and provides global custom research services, including market assessments and physician surveys.

In other financing activity:

Omega Healthcare Investors (Timonium, Maryland) reported a public offering of 6 million shares of its common stock. The last reported sale of Omega's common stock on the New York Stock Exchange on Monday was $17.23. Omega said it intends to use the proceeds to repay indebtedness outstanding under its senior credit facility, for working capital and general corporate purposes. UBS Investment Bank was the sole book running manager and Stifel Nicolaus was the co-manager on this offering.

No Comments